Danaher Corporation (DHR): Saudi Central Bank exited its position 256 shares
Saudi Central Bank exited its position in Danaher Corporation, per its Q2 2025 13F.
- 256
- Prior-quarter shares · no longer reported
- Holdings as of
- Jun 30, 2025
- Filed
- Aug 14, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 8, 2015CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
- Oct 29, 2024CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
- May 12, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
- Jun 11, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
- Jun 12, 2025CongressDisclosed sale of DHR — reported range $50,001 - $100,000
- Jul 22, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
What came next
- Aug 22, 2025InsiderDirector sold ~$586K of DHR shares in the open market
- Aug 28, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
- Sep 3, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
- Sep 9, 2025Company filing · Form 8-K · Bylaws or charter, Other newsChanged its bylaws, charter or fiscal year, and reported other company news
- Sep 19, 2025FDARecall: DxI 9000 Access Immunoassay Analyzer, Part Number C11137
- Sep 19, 2025FDARecall: DxC 500i Clinical Analyzer Modules, DxC 500 AU Module w/ISE, DxC 500i (Part Number C63522), DxC 500 AU Module, DxC 500i (Part Number C63521), and Access 2 Modu…
- Sep 22, 2025FDARecall: DxFLEX Flow Cytometer Catalog Number C78500 UDI-DI code: 15099590754013 The DxFLEX Flow Cytometer is intended for use as an in vitro diagnostic device for immu…
- Sep 25, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
- Oct 1, 2025FDARecall: Beckman Coulter UniCel DxI 600, Part Numbers: A71460, A30260; Photometric Chemistry Analyzer
- Oct 1, 2025FDARecall: Beckman Coulter UniCel DxI 800, Part Numbers: 973100, A71456; Photometric Chemistry Analyzer
- Oct 7, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
- Oct 14, 2025FDARecall: BECKMAN COULTER BICARBONATE REF: OSR6137 OSR6237 OSR6637 OSR6x37 Bicarbonate is a system reagent for the quantitative determination of Bicarbonate in human ser…
- Oct 21, 2025Company filing · Form 8-K · ResultsReported its results
- Oct 30, 2025FDARecall: Brand Name: Xpert¿ BCR-ABL Ultra Model/Catalog Number: GXBCRABL-10
- Oct 30, 2025FDARecall: Brand Name: Xpert¿ BCR-ABL Ultra Model/Catalog Number: GXBCRABL-US-10
- Oct 31, 2025Insider · 1 personInsiders: 3 sales (~$129.6M)
- Nov 5, 2025FDARecall: Xpert MTB/RIF. Model Number: GXMTB/RIF-US-10.
- Nov 6, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 6, 2025, John T. Schwieters notified Danaher’s Board of Directors (“Board”) that he has decided not to stand for reelection at the Company’s 2026 annual meeting of shareholders (“2026 Annual Meeting”), and will retire from the Danaher Board as of the 2026 Annual Meeting.”
- Nov 7, 2025FDARecall: Access 2 Reaction Vessels, individual, disposable, plastic tubes used to process patient, quality control and calibration samples on the Access 2 Immunoassay s…
- Nov 10, 2025FDARecall: COULTER DxH Diluent, REF 628017 COULTER DxH ECO Diluent REF C67250 For use as an isotonic buffered diluent in conjunction with a cyanide-free lytic agent for c…
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Danaher Corporation
For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.
How this filing works
Explore the data
Common questions
What does this filing report about Danaher Corporation (DHR) stock?
Saudi Central Bank exited its position in Danaher Corporation, per its Q2 2025 13F. Held the prior quarter, no longer listed per its Q2 2025 13F.
When did it happen, and when was it made public?
Holdings as of: Jun 30, 2025. Filed: Aug 14, 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Danaher Corporation recently?
For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days. They are listed on the DHR page.
Does this mean DHR stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Danaher Corporation
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
Everything OQRO holds on this company is on its DHR page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
